Back to search

The University of Edinburgh

Vasoactive hormone studies in man using urotensin II and vasopressin

Abstract

dc:description.abstract

BACKGROUND Within this thesis we have examined the effects on vascular tone of two peptide hormones, urotensin II and vasopressin. Human urotensin II is a novel vasoactive peptide hormone with receptors located on human arterial tissue and ventricular myocytes. It is the most potent arterial vasoconstrictor yet discovered and has a sustained effect on blood vessels from a variety of species with potency 28 to 50 fold greater than endothelin-1. Vasopressin has however, been known to have arterial vasoconstrictor properties in man in vivo for many years. However, peptide antagonists for the VI receptor, mediating vasoconstriction, and the V2 receptor, mediating vasodilatation, have often been of poor selectivity and subject to inter-species variation, thus clouding the true arterial pharmacodynamic effects of vasopressin. Two novel peptidic arginine vasopressin antagonists have recently been produced and offer potentially more receptor selectivity

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2007

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Affolter, Jonathan Theodore

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1842/28010

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Affolter, Jonathan Theodore. Vasoactive hormone studies in man using urotensin II and vasopressin. The University of Edinburgh, 2007. http://hdl.handle.net/1842/28010